Court rules in favor of Watson in generic Fentora patent suit

A generic painkiller made by Watson Pharmaceuticals does not infringe on the patent covering the branded version, a U.S. District Court has ruled.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

© 2012 Drug Store News. All Rights Reserved.